Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy
Enregistré dans:
Auteurs principaux: | Mathieu Roumiguie, Alberto Contreras-Sanz, Gunjan Kumar, Peter C. Black |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4fb0060813c64bb1878148046dd05100 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Reply to: Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy
par: Ann Taber, et autres
Publié: (2021) -
Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis
par: Ann Taber, et autres
Publié: (2020) -
Cisplatin is retained in the cochlea indefinitely following chemotherapy
par: Andrew M. Breglio, et autres
Publié: (2017) -
A response prediction model for taxane, cisplatin, and 5-fluorouracil chemotherapy in hypopharyngeal carcinoma
par: Qi Zhong, et autres
Publié: (2018) -
Clinical Impact of Molecular Subtyping of Pancreatic Cancer
par: Zhou Xu, et autres
Publié: (2021)